NCCN: Cancer Drug Shortages Remain a Challenge for Clinicians
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
FRIDAY, June 28, 2024 -- Almost 90 percent of medical centers report cancer drug shortages, which often impact clinical trials, according to the results of a National Comprehensive Cancer Network survey.
Following data published one year ago and six months ago illustrating shortages of crucial cancer drugs, the National Comprehensive Cancer Network published new results from its most recent survey on cancer drug shortages in the United States.
According to the survey, 89 percent of the 28 cancer centers surveyed reported that cancer drugs are in short supply, most often vinblastine (57 percent), etoposide (46 percent), and topotecan (43 percent). Eleven and 7 percent of centers reported that carboplatin and cisplatin, respectively, were in short supply. More than half of the centers surveyed (56 percent) reported being able to treat all patients according to the intended dose and schedule by using mitigation strategies, with waste management strategies and limiting use of current stock (80 and 53 percent, respectively) the most common mitigation strategies implemented. Drug shortages impacted clinical trials at 43 percent of the centers surveyed, most often by greater administrative burden and reduction in enrollments (83 and 58 percent, respectively).
"The current situation underscores the need for sustainable, long-term solutions that ensure a stable supply of high-quality cancer medications," Alyssa Schatz, M.S.W., from the National Comprehensive Cancer Network, said in a statement. "The federal government has a key role to play in addressing this issue. Establishing economic incentives, such as tax breaks or manufacturing grants for generic drugmakers, will help support a robust and resilient supply chain -- ultimately safeguarding care for people with cancer across the country."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-06-29 07:15
Read more
- Prepping for Colonoscopy? An Expert Offers Tips to Make Things Easier
- Women With Severe Maternal Morbidity Less Likely to Have Subsequent Birth
- FDA Approves Cobenfy for Adults With Schizophrenia
- President-Elect Trump to Pick Mehmet Oz to Head CMS
- Skin Patch Could Monitor Your Blood Pressure
- Money, Education Helps Determine Your Odds for Dementia
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions